Advertisement

Long-acting water-stable organosilane agent and its sustained effect on reducing microbial load in an intensive care unit

      Background

      Contaminated hospital surfaces contribute significantly to the transmission of health care-associated infections. Although disinfectants reduce bioburden by up to 99%, bacterial growth can rebound within hours to precleaning levels. We tested the effectiveness of an innovative, long-acting water-stable organosilane (WSO) to achieve sustained decreases in bioburden on hard surfaces.

      Methods

      A 5-month prospective, randomized, double-blind controlled study was performed. Eighteen intensive care unit rooms were randomly divided into placebo or treatment groups. Hard surfaces in all rooms were cleaned using the same protocol, except the placebo surfaces were cleaned with an inert saline solution and the treatment surfaces were treated with the WSO. Binomial regression with repeated measures were used to assess mean reductions in total bioburden as measured by colony forming units.

      Results

      The placebo resulted in average reductions in total colony forming units of 35% to 40% (relative risk reduction [RRR], 0.65; P < .01) and the WSO group averaged reductions of colony forming units by 66% to 99% (RRR, 0.55; P < .001). Total Staphylococcus aureus increased among the placebo rooms 30% (RRR, 0.69; P < .001), whereas in treatment rooms there was a reduction of 50%-60% (RRR, 0.57; P < .01). Although both sets of rooms saw reductions in bioburden or colony forming units, application of the WSO resulted in larger reductions. There was also greater variability in reductions in the placebo arm.

      Conclusion

      This is the first randomized, double-blind controlled study of an innovative WSO on high-touch hard surfaces at risk for high bioburdens. Sustained reductions of bioburden with the monthly application of this unique WSO may be associated with significant reductions in the risk of health care-associated infections.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Magill S.S.
        • Edwards J.R.
        • Bamberg W.
        • Beldavs Z.G.
        • Dumyati G.
        • Kainer M.A.
        • et al.
        Multistate point-prevalence survey of health care-associated infections.
        N Engl J Med. 2014; 370: 1198-1208
        • Healthcare-associated Infections
        Centers for Disease Control and Prevention website.
        (Available from:) (Accessed March 2, 2016)
        • Zimlichman E.
        • Henderson D.
        • Tamir O.
        • Franz C.
        • Song P.
        • Yamin C.K.
        • et al.
        Health care–associated infections a meta-analysis of costs and financial impact on the US health care system.
        JAMA. 2013; 173: 2039-2046
        • Evans M.
        Half hospitals penalized for hospital-acquired conditions are repeat offenders.
        (Modern Healthcare. Website; Available from:) (Accessed September 27, 2016)
        • Huang S.S.
        • Datta R.
        • Platt R.
        Risk of acquiring antibiotic-resistant bacteria from prior room occupants.
        Arch Intern Med. 2006; 166: 1945-1951
        • Boyce J.M.
        Environmental contamination makes an important contribution to hospital infection.
        J Hosp Infect. 2007; 65: 50-54
        • Weber D.J.
        • Rutala W.A.
        • Miller M.B.
        • Huslage K.
        • Sickbert-Bennet E.
        Role of hospital surfaces in the transmission of emerging health care associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
        Am J Infect Control. 2010; 38: S25-S33
        • Otter J.
        • Yezli S.
        • French G.
        The role played by contaminated surfaces in the transmission of nosocomial pathogens.
        Infect Control Hosp Epidemiol. 2011; 32: 687-699
        • Otter J.A.
        • Yezli S.
        • Salkeld J.A.G.
        • French G.L.
        Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings.
        Am J Infect Control. 2013; 41: S6-11
        • Weber D.J.
        • Anderson D.J.
        • Sexton D.J.
        • Rutala W.A.
        Role of the environment in the transmission of Clostridium difficile in health care facilities.
        Am J Infect Control. 2013; 41: S105-S110
        • Kramer A.
        • Schwebke I.
        • Kampf G.
        How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.
        BMC Infect Dis. 2006; 6: 130
        • Attaway H.H.
        • Fairey S.
        • Steed L.
        • Salgado C.D.
        • Michels H.T.
        • Schmidt M.G.
        Intrinsic bacterial burden associated with intensive care unit hospital beds: effects of disinfection on population recovery and mitigation of potential infection risk.
        Am J Infect Control. 2012; 40: 907-912
        • Hardy K.J.
        • Gossain S.
        • Henderson N.
        • Drugan C.
        • Oppenheim B.A.
        • Gao F.
        • et al.
        Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour.
        J Hosp Infect. 2007; 66: 360-368
        • Baxa D.
        • Shetron-Rama L.
        • Golembieski M.
        • Golembieski M.
        • Jain S.
        • Gordon M.
        • et al.
        In vitro evaluation of a novel process for reducing bacterial contamination of environmental surfaces.
        Am J Infect Control. 2011; 39: 483-487
        • Perez V.
        • Mena K.D.
        • Watson H.N.
        • Prater R.B.
        • McIntyre J.L.
        Evaluation and quantitative microbial risk assessment of a unique antimicrobial agent for hospital surface treatment.
        Am J Infect Control. 2015; 43: 1201-1207
        • Rutala W.A.
        • Weber D.J.
        • Healthcare Infection Control Practices Advisory Committee
        Guideline for disinfection and sterilization in healthcare facilities.
        (Available from:) (Accessed March 2, 2016; Published 2008)
        • Centers for Disease Control and Prevention
        Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.
        MMWR. 2002; 51: 1-48